siRNA
December 17, 2025
Alnylam Announces Major Expansion of U.S. Pharmaceutical Manufacturing Facility
$250 million investment will add new capacity and siRNA enzymatic ligation capabilities to Alnylam's Norton, Massachusetts site
Read More ›
September 30, 2025
How Alnylam’s Manufacturing Investments Bring RNAi Therapeutics to More Patients, Faster
Translating our pioneering work in RNAi not only requires innovation in the lab - it requires innovation in how we make our medicines.
Read More ›
FOLLOW US
